1. Home
  2. GEOS vs ACET Comparison

GEOS vs ACET Comparison

Compare GEOS & ACET Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GEOS
  • ACET
  • Stock Information
  • Founded
  • GEOS 1980
  • ACET 1947
  • Country
  • GEOS United States
  • ACET United States
  • Employees
  • GEOS N/A
  • ACET N/A
  • Industry
  • GEOS Industrial Machinery/Components
  • ACET Biotechnology: Pharmaceutical Preparations
  • Sector
  • GEOS Industrials
  • ACET Health Care
  • Exchange
  • GEOS Nasdaq
  • ACET Nasdaq
  • Market Cap
  • GEOS 72.9M
  • ACET 63.5M
  • IPO Year
  • GEOS 1997
  • ACET N/A
  • Fundamental
  • Price
  • GEOS $17.20
  • ACET $0.82
  • Analyst Decision
  • GEOS
  • ACET Buy
  • Analyst Count
  • GEOS 0
  • ACET 5
  • Target Price
  • GEOS N/A
  • ACET $5.33
  • AVG Volume (30 Days)
  • GEOS 191.3K
  • ACET 524.7K
  • Earning Date
  • GEOS 08-07-2025
  • ACET 11-05-2025
  • Dividend Yield
  • GEOS N/A
  • ACET N/A
  • EPS Growth
  • GEOS N/A
  • ACET N/A
  • EPS
  • GEOS N/A
  • ACET N/A
  • Revenue
  • GEOS $115,527,000.00
  • ACET N/A
  • Revenue This Year
  • GEOS N/A
  • ACET N/A
  • Revenue Next Year
  • GEOS N/A
  • ACET N/A
  • P/E Ratio
  • GEOS N/A
  • ACET N/A
  • Revenue Growth
  • GEOS N/A
  • ACET N/A
  • 52 Week Low
  • GEOS $5.51
  • ACET $0.45
  • 52 Week High
  • GEOS $21.60
  • ACET $1.57
  • Technical
  • Relative Strength Index (RSI)
  • GEOS 51.00
  • ACET 58.29
  • Support Level
  • GEOS $16.10
  • ACET $0.77
  • Resistance Level
  • GEOS $17.29
  • ACET $0.90
  • Average True Range (ATR)
  • GEOS 1.23
  • ACET 0.05
  • MACD
  • GEOS -0.35
  • ACET 0.01
  • Stochastic Oscillator
  • GEOS 29.37
  • ACET 59.61

About GEOS Geospace Technologies Corporation (Texas)

Geospace Technologies Corp is engaged in designing and manufacturing seismic instruments and non-seismic equipment used in the oil and gas industry. The company has three different segments: oil and gas markets, adjacent markets, and emerging markets. The oil and gas markets segment, which accounts for the majority of the company's revenue, includes traditional exploration products, wireless exploration products, and reservoir characterization products and services. The adjacent markets business is closely tied to the oil and gas markets and includes imaging products and industrial products. The company operates globally across Asia, Canada, Europe, the United States, South America, Mexico, and other regions with a majority of its revenue being generated within the United States.

About ACET Adicet Bio Inc.

Adicet Bio Inc is a clinical-stage biotechnology company discovering and developing allogeneic gamma delta T cell therapies for cancer and other diseases. Its product candidate, ADI-001, a first-in-class allogeneic gamma delta T cell therapy expressing a CAR targeting CD20, is being developed for the potential treatment of autoimmune diseases and relapsed or refractory aggressive B cell non-Hodgkin's lymphoma. Their pipeline also includes its preclinical candidate, ADI-270, an armored gamma delta CAR T cell product candidate targeting renal cell carcinoma, with potential for other CD70+ solid tumor and hematological malignancies indications.

Share on Social Networks: